Market intelligence for the peptide supply chain
Companies · China

US removes WuXi AppTec from military-company list

November 14, 2026 · TideMetrix Brief
TideMetrix TakeWuXi AppTec's removal from a US military-company list lifts one regulatory designation affecting a major peptide and oligonucleotide manufacturer. But the court-driven decision leaves broader procurement restrictions and legal uncertainty unresolved.

The US Department of Defense has removed WuXi AppTec from its Section 1260H list of Chinese military companies following a federal court injunction, reversing a designation that had raised regulatory concerns around one of the world's major pharmaceutical contract manufacturers.

The decision was published in the Federal Register on November 10, following a preliminary injunction issued on August 7 by the US District Court for the District of Columbia.

The injunction prevents the Department of Defense from enforcing or giving effect to the designation challenged by WuXi AppTec. The department's notice expressly preserves the possibility of adding the company to the list again on additional or supplementary grounds.

WuXi AppTec confirmed the development in a November 10 announcement, saying it learned of the removal decision the previous day.

The company operates a substantial pharmaceutical development and manufacturing platform, including peptide and oligonucleotide services. Its regulatory status is therefore relevant to pharmaceutical companies evaluating contract manufacturing partners and supply-chain exposure.

For peptide manufacturers and buyers, the decision removes one specific US government designation but does not establish unrestricted procurement eligibility. Other applicable laws, contracting requirements and supplier due-diligence obligations must be assessed separately.

The delisting also does not constitute FDA manufacturing approval or change the company's underlying production capacity. The continuing litigation and possibility of future regulatory action remain relevant to sourcing decisions.

Sources

← Back to News